September 3rd 2024
The updated COVID-19 vaccine targets the currently circulating Omicron variant JN.1 strain of SARS-CoV-2.
August 23rd 2024
Topics include declining vaccine coverage among kindergarten-aged children and key changes in recommendations for adult vaccination.
August 22nd 2024
The updated COVID-19 vaccines will include a monovalent component corresponding to KP.2, a strain of the Omicron variant of SARS-CoV-2.
July 9th 2024
A new study shows that higher vaccination rates were associated with a decrease in the prevalence of parent-reported asthma symptoms in children.
June 28th 2024
Individuals 6 months and older should receive updated COVID-19 and influenza vaccines for the 2024-2025 respiratory virus season, the agency recommended.
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of September 30, 2021
Data from the CDC on the Delta variant and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
Health Care Workers Likely to Recommend COVID-19 Vaccine to Patients Based on Safety Messaging, Survey Finds
Survey authors said findings merit further research into how to increase health care workers' confidence in discussing and recommending COVID-19 vaccines with patients.
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of September 29, 2021
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of September 28, 2021
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of September 27, 2021
COVID-19 Boosters: Hope or Hype?
Infectious disease expert and NIH-funded researcher Rodger MacArthur, MD, has questions about the evidence on which the Pfizer booster shot recommendations are based.
Study: Safety Data on HPV Vaccine Improving, but More Parents Still Concerned
A new analysis showed a near 78% increase in citing safety concerns among parents with HPV vaccine hesitancy, contrary to no observed changes in serious adverse event reporting.
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of September 24, 2021
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of September 23, 2021
FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine Booster for Select Groups
The Pfizer-BioNTech booster shot is authorized for use in persons aged ≥65 years, at high risk of severe disease, and who have frequent exposure to the virus increasing risk for severe infection.
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of September 22, 2021
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of September 21, 2021
J&J Preprint Data Show Real-world Durability, Promise for Booster Shot Against COVID-19
Strong evidence from a large, real-world evidence study, and preliminary data from a phase 3 booster-dose trial may support J&J's next steps toward FDA authorization of a COVID-19 booster.
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of September 20, 2021
CDC: Moderna Vaccine Shows Highest Efficacy Against Hospitalizations in Healthy Adults
In a new analysis of adults without immunocompromising conditions, vaccine effectiveness against hospitalization was higher for Moderna than Pfizer and Johnson & Johnson.
Pfizer-BioNTech Report COVID-19 Vaccine is Safe, Effective in Children Aged 5 to 11 Years
Pfizer/BioNTech report "robust" antibody response to COVID-19 vaccine in children aged 5 to 11 years with safety profile comparable to that seen in persons aged 16 to 25 years.
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of September 17, 2021
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of September 16, 2021
COVID-19 Hospitalizations for Unvaccinated Cost US Billions
Avoidable COVID-19 hospitalizations for unvaccinated persons in the US have cost an estimated $5 billion since June, according to a new study.
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of September 15, 2021
10 States with the Highest COVID-19 Vaccination Rates, 5 with the Lowest
According to the CDC, Vermont right now has the highest and Wyoming the lowest percentage of its state's population fully vaccinated against COVID-19.
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of September 13, 2021
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of September 10, 2021
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of September 9, 2021
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of September 7, 2021
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of September 2, 2021
3 Flu Vaccine Conundrums: Who Needs a Shot and When?
Who needs a flu shot and when is not always straightforward. This year it's more important than ever to know what the CDC recommends. Start with 3 short scenarios.
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of September 1, 2021
Myocarditis as Metaphor for COVID-19 Vaccine Risk-Benefit Calculation
There is a very small risk of myocarditis after the second dose of COVID-19 mRNA vaccines. How small? And how small vs the risks associated with infection?
Flu Seasons Compared: 8 Questions on 2020-2021 and What Might Happen This Year
Test what you know about flu seasons past and what the flu season present might have in store with 8 questions based on the history. Remember: Winter is coming.